an insider trading charges derail political campaigns? Should you trust a fund manager over a doctor? And how many rats would you trade for a cow?

We discuss all that and more in the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Tune in for a conversation about the charges against Rep. Chris Collins, who is accused of illegally tipping off his son that their big biotech investment was about to go belly-up. Then we delve into a contentious online dispute between Impossible Foods, which hopes to reduce animal suffering, and PETA, which hopes to reduce animal suffering. And we’ll explore an increasingly common question in biotech: When Wall Street says data are bad but doctors argue otherwise, what are you supposed to conclude? Finally we’ll embark upon a lightning round, covering the latest in drug-price finger-pointing and what you should call a unicorn that has outgrown its horn.

For more on what we cover, here’s the news on Collins; here’s PETA’s problem with Impossible foods, and here’s the company’s response; and here’s the latest example of doctors at odds with Wall Street.


We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email readoutloud@statnews.com.

Interested in sponsoring a future episode of “The Readout LOUD”? Email us at marketing@statnews.com.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy